Dextrose (50%) Injection
Last Updated: July 6, 2017
Status: Current
Dextrose (50%) Injection
Products Affected - Description
-
50% Dextrose intravenous injection, Amphastar
50 mL Luer-Jet syringe, 10 count (NDC 76329-3301-01)
50% Dextrose intravenous injection, Pfizer
50 mL LifeShield syringe, 10 count (NDC 00409-4902-34)
50 mL LifeShield syringe, 10 count (NDC 00409-4902-34)
50 mL Ansyr II Luer Lock syringe, 10 count (NDC 00409-7517-16)
50 mL vial, 25 count (NDC 00409-6648-02)
Reason for the Shortage
-
- Amphastar has 50% dextrose injection on shortage due to increased demand.
- Pfizer has 50% dextrose injection on shortage due to manufacturing delays.
Available Products
-
There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Amphastar has 50% dextrose 50 mL syringes on allocation and is regularly releasing product.
- Pfizer has 50% dextrose 50 mL LifeShield syringes, Ansyr syringes, and vials on back order and the company estimate a release date of July 2017.
Safety
-
FDA has extended the expiration dating for certain lots of 50% dextrose 50 mL Abboject syringes.
Related Shortages
| Dextrose (25%) Injection | Current |
Updated
July 6, June 16 and 6, May 2, April 20, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
